
Sep 29, 2026
Does Zepbound Cause Hair Loss? What the Trial Numbers Mean
Hair loss appears in Zepbound’s U.S. label. Understand the trial rates, delayed shedding, possible causes, and the patterns to discuss with your clinician.
Read article →
Glowise Blogs
Practical, evidence-aware information designed to help you understand what you track and prepare better questions for qualified healthcare professionals.

Sep 29, 2026
Hair loss appears in Zepbound’s U.S. label. Understand the trial rates, delayed shedding, possible causes, and the patterns to discuss with your clinician.
Read article →

Sep 29, 2026
Compare U.S. storage limits for Zepbound single-dose pens and vials, multi-dose vials, and KwikPen, including room-temperature and discard rules.
Read article →

Sep 24, 2026
Feeling unusually tired on Wegovy? See what the U.S. label says, why no fixed duration can be promised, what to record, and when to get medical help.
Read article →

Sep 23, 2026
Find U.S. missed-dose rules for Ozempic injections and pills, Wegovy injections and pills, plus what to do with a compounded product or an uncertain dose.
Read article →

Sep 22, 2026
For an unopened compounded semaglutide vial, the pharmacy label and beyond-use date matter more than a universal online shelf-life number. Learn what to check.
Read article →

Sep 14, 2026
Learn what lean-mass changes do and do not mean during GLP-1 weight loss, plus practical ways to support muscle, strength, nutrition, and function.
Read article →

Sep 10, 2026
Mounjaro can be taken once weekly at any time of day, with or without meals. Learn how to keep a routine question distinct from prescription instructions.
Read article →

Sep 10, 2026
Exercise on a GLP-1 medication does not need one fixed workout plan. Use public-health guidance and a flexible routine review to choose a workable next step.
Read article →
How we approach health content
Glowise content is educational and does not diagnose, prescribe, or replace professional care. Health claims should be evidence-aware, reviewed under our editorial process, and clear about uncertainty.